IRIS
CAMPIONE, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.041
EU - Europa 2.537
AS - Asia 665
OC - Oceania 12
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 11
AF - Africa 10
Totale 34.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.010
IT - Italia 608
IE - Irlanda 514
CN - Cina 427
UA - Ucraina 320
DE - Germania 288
FR - Francia 188
SE - Svezia 173
GB - Regno Unito 151
KR - Corea 95
PL - Polonia 95
FI - Finlandia 77
RU - Federazione Russa 57
BE - Belgio 34
IN - India 21
JP - Giappone 21
CA - Canada 19
UZ - Uzbekistan 17
HK - Hong Kong 16
KG - Kirghizistan 15
AU - Australia 10
EU - Europa 10
IL - Israele 10
MX - Messico 10
VN - Vietnam 10
BR - Brasile 7
EG - Egitto 7
NL - Olanda 7
ES - Italia 6
IR - Iran 6
SG - Singapore 6
MY - Malesia 5
RO - Romania 5
ID - Indonesia 4
GR - Grecia 3
TH - Thailandia 3
TR - Turchia 3
AR - Argentina 2
DK - Danimarca 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 34.288
Salva come PNG Salva come JPEG
Città #
Wilmington 8.811
Houston 8.233
Woodbridge 6.851
Fairfield 1.435
Chandler 773
Ashburn 660
Seattle 610
Ann Arbor 540
Cambridge 502
Dublin 460
Medford 330
Jacksonville 272
Rome 251
Dearborn 194
Beijing 177
New York 168
Lawrence 157
San Diego 116
Zhengzhou 98
Menlo Park 96
Kraków 90
Redwood City 47
Seoul 41
Milan 33
Brussels 31
London 30
Cedarhurst 28
Mülheim 28
Falls Church 24
Nanjing 23
Norwalk 22
Shanghai 20
Atlanta 18
Boardman 17
Palo Alto 17
Hefei 15
Helsinki 15
Toronto 15
Verona 15
Engelhard 14
Naples 13
Detroit 12
Mountain View 12
San Mateo 12
University Park 11
Kilburn 10
Esslingen am Neckar 9
Guangzhou 9
Jinan 9
Nanchang 9
Redmond 9
Creede 8
Manitou Springs 8
Wuhan 8
Dong Ket 7
Kunming 7
Los Angeles 7
Nuremberg 7
Petah Tikva 7
Phoenix 7
Saint Petersburg 7
Cairo 6
Chicago 6
Sydney 6
Tokyo 6
Aprilia 5
Auburn Hills 5
Hangzhou 5
Indiana 5
Kuala Lumpur 5
Paris 5
Pune 5
San Jose 5
São Paulo 5
Viterbo 5
Ancona 4
Augusta 4
Center 4
Central 4
Chongqing 4
Fuzhou 4
Hackensack 4
Hong Kong 4
Marana 4
Mexico City 4
Monterrey 4
Nürnberg 4
Palermo 4
Renton 4
San Antonio 4
Sedico 4
St. George 4
Wandsworth 4
Acton 3
Ardea 3
Asolo 3
Bologna 3
Boydton 3
Council Bluffs 3
Coushatta 3
Totale 31.632
Salva come PNG Salva come JPEG
Nome #
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.161
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 704
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 642
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 569
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 438
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 422
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 415
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 408
CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports. 405
Actinic keratosis treated with an immune response modifier: a case report of six patients 402
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 402
Tazarotene as alternative topical treatment for onychomycosis 401
Pyoderma gangrenosum in refractory celiac disease: a case report 397
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 391
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 388
Fungistatic activity of all-trans retinoic acid against Aspergillus fumigatus and Candida albicans 387
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 381
Severe acne successfully treated with etanercept 378
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 374
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 370
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 369
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 362
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 362
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 360
Connexin 26 (GJB2) mutations, causing KID Syndrome, are associated with cell death due to calcium gating deregulation 360
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 356
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis 356
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 354
Confocal reflectance microscopy in pityriasis rubra pilaris 352
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 350
Bilateral Thoracoscopic T2 to T3 Sympathectomy Versus Botulinum Injection in Palmar Hyperhidrosis 350
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 346
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 336
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 335
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 334
Expression and potential role of cellular retinol binding protein I in psoriasis 332
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 331
Pyoderma vegetans and ulcerative colitis 330
Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss 330
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 330
Blood MUC-18/MCAM expression in patients with melanoma: A suitable marker of poor outcome 328
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 327
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 325
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies 322
Dermatomyositis associated with ovarian transitional cell carcinoma 321
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 321
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 317
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene J Invest Dermatol. 2007 Sep;127(9):2271-3. 313
Immunologic biomarkers for clinical and therapeutic management of psoriasis 312
Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases 310
Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study 308
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 306
Nodular morphea in a patient with Steinert disease 306
Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma 303
A safety evaluation of guselkumab for the treatment of psoriasis 303
Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma 302
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics 295
High-dose Intravenous Immunoglobulin for Severe Drug Reactions: Efficacy in Toxic Epidermal Necrolysis 292
Kruppel-like factor 4 regulates keratinocyte senescence 290
Current developments in pharmacotherapy for actinic keratosis 289
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomas 288
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter cream 288
Progressive late-onset of cutaneous angiomatosis as possible sign of cerebral cavernous malformations 287
Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in day surgery unit. 283
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab 281
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 266
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy 264
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution 256
Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast 249
Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review 246
Non-familial porphyria cutanea tarda: a case report of a rare disease 235
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial 234
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2 234
Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial 234
Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi 230
Bednar Tumour Occurring after Malignant Melanoma Excision 230
Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections 221
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 220
Potential of Curcumin in Skin Disorders 215
Investigational drugs currently in phase II clinical trials for actinic keratosis 213
Drug-induced lichen planus pigmentosus: Do supportive and complementary drugs count? 209
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 201
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy 200
Skin immunity and its dysregulation in psoriasis 199
Sofosbuvir induced leucocytoclasic vasculitis: a case report 194
Birt–Hogg–Dubé syndrome, from non-invasive dermatologic assessment to gene testing, molecular and ultrastructural histologic analysis 193
New local treatment for photoaging using a formulation containing piroxicam 0.8% and sunscreen 181
Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: An open label pilot study 177
Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice 175
The E3 ligase Itch knockout mice show hyperproliferation and wound healing alteration 162
Transglutaminase 3 is expressed in basal cell carcinoma of the skin 155
Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo 154
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 152
Cellular retinoic acid binding protein-II expression and its potential role in skin aging 151
Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study 149
Luteolin-7-O-ß-D-glucoside inhibits cellular energy production interacting with HEK2 in keratinocytes 146
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 144
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 141
The dark side of gefitinib: reflectance confocal microscopy applied to hair hyperpigmentation 136
Dermoscopic Analysis of 72 “Atypical” Seborrheic Keratoses|Análisis dermatoscópico de 72 queratosis seborreicas «atípicas» 135
Totale 30.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.029
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.029
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.652 0 0 0 0 0 0 0 0 0 0 769 883
2019/20209.443 752 691 554 825 796 940 845 845 970 869 647 709
2020/20217.416 682 739 660 878 1.031 898 996 783 166 251 204 128
2021/20221.811 95 185 86 75 77 165 141 90 137 140 125 495
2022/20232.246 231 269 73 245 218 505 199 118 193 27 115 53
2023/2024866 109 34 70 40 81 213 134 71 24 86 4 0
Totale 35.270